Eli Lilly Suspends COVID-19 Antibody Therapy Trial Over “Potential Safety Concern”
By Tyler Durden Barely a week after applying for emergency use approval from the FDA for one of its COVID-19 antibody therapeutics, it appears trials for one of Eli Lilly’s therapeutic drugs focused on the virus (Eli Lilly is working on more than just one)…